Endoscopy Device Market

The Endoscopy Device market is anticipated to expand from US$ 34.80 billion in 2024 to US$ 59.53 billion by 2031, with a projected CAGR of 6.9% during the period of 2025-2031.

Market Insights and Analyst Perspective:

Endoscopy is a minimally invasive surgical technique used to visualize the internal organs of the human body and is also applicable in surgeries on various organs. This procedure utilizes a small flexible tube called an endoscope, which is equipped with a camera to provide a clear view of the organ being examined. Depending on the area of interest, different types of scopes are available, including arthroscopes, bronchoscopes, laparoscopes, and hysteroscopes. Additionally, various other devices and instruments are utilized during endoscopy to enhance visualization, ensure sterilization, and improve imaging quality.

Factors Driving Growth:

Rising Demand for Minimally Invasive Procedures

The increasing preference for minimally invasive techniques in surgical practices signifies a notable transformation in medical approaches and patient choices. This trend is fueled by the aim to reduce the invasiveness of procedures, lower associated risks, and facilitate quicker recovery times. Endoscopy, as a minimally invasive surgical method, involves smaller incisions, shorter recovery periods, and improved visibility into the internal body cavity. Surgeons can visualize and operate within the body using an endoscope without the need for large incisions. Minimally invasive methods generally involve smaller cuts and the use of specialized tools and technologies to access various organs, resulting in shorter hospital stays and reduced scarring. Furthermore, patients typically experience less pain and a faster return to their normal activities. Surgeons are adopting these techniques due to their advantages, alongside advancements in medical devices and surgical expertise. Consequently, healthcare institutions are investing in training their medical personnel and acquiring the necessary equipment to cater to the rising demand for minimally invasive endoscopy surgeries, thus enhancing treatment options and overall healthcare experiences for patients.

Strategic Insights

Report Segmentation and Scope:

The endoscopy device market is categorized based on product, application, and end user. In terms of product, the market is divided into endoscopes, visualization systems, accessories, and other endoscopy devices. The endoscopes segment is further divided into flexible endoscopes, rigid endoscopes, robot-assisted endoscopes, and capsule endoscopes. The visualization systems segment is further categorized into wireless displays and monitors, light sources, video processors, endoscopic cameras, video recorders, video converters, carts, transmitters and receivers, camera heads, and other instruments. The other endoscopy devices segment includes electronic and mechanical instruments. The accessories segment is subdivided into cleaning brushes, overtubes, surgical dissectors, light cables, fluid flushing devices, needle holders/needle forceps, mouthpieces, biopsy valves, and others. By application, the endoscopy device market is segmented into gastroscopy, laparoscopy, arthroscopy, otoscopy, urology endoscopy, bronchoscopy, laryngoscopy, and other applications. The market is also segmented by end user into hospitals, ambulatory surgical centers, and others.

Segmental Analysis:

In terms of product, the endoscopes segment accounted for the largest share of the endoscopy device market in 2022. The visualization systems segment is projected to exhibit the highest CAGR during 2022-2030. Visualization systems utilized in endoscopy procedures are essential for capturing high-quality images and videos. This segment includes components such as wireless displays and monitors, light sources, video processors, endoscopic cameras, video recorders, video converters, carts, transmitters and receivers, camera heads, and other instruments. Companies like Boston Scientific Corporation and KARL STORZ SE & Co. KG are key providers of visualization systems in the endoscopy device market.

Regarding application, the gastroscopy segment held the largest share of the endoscopy device market in 2022, while the laparoscopy segment is expected to show the highest CAGR during 2022-2030. Gastroscopy, also referred to as upper endoscopy, involves examining the upper gastrointestinal tract, including the esophagus, stomach, and duodenum (the initial part of the small intestine). It is utilized to diagnose conditions such as ulcers, tumors, inflammation, and gastroesophageal reflux disease (GERD). Endoscopy devices designed for gastroscopy feature flexible endoscopes equipped with advanced imaging capabilities, including high-definition cameras and optical enhancements.

By end user, the hospitals segment represented the largest share of the endoscopy device market in 2022 and is expected to register the highest CAGR during 2022-2030. Hospitals encompass a wide range of medical facilities, from community hospitals to large academic medical centers, and are significant end users of endoscopy devices. The demand for endoscopy devices in hospitals is primarily driven by a high volume of patients, attributed to comprehensive care delivery, inpatient and outpatient services, and advanced procedures. Hospitals are equipped to perform complex endoscopic procedures, including surgeries, advanced imaging, and specialized therapeutic endoscopy. Endoscopes are also employed to examine the interiors of hollow organs or cavities within the body. Certain endoscopic examinations, such as cystoscopies, are typically conducted in hospital outpatient settings, while ureteroscopy procedures for managing or removing kidney stones are performed in operating rooms. Similarly, most ENT endoscopies, such as those assessing a patient’s nose or throat for breathing or swallowing issues, are carried out in both inpatient and outpatient hospital environments.

Regional Analysis:

Geographically, the endoscopy device market is divided into Asia Pacific, Europe, the Middle East & Africa, North America, and South & Central America. In 2022, North America held the largest share of the global market, while Asia Pacific is expected to exhibit the highest CAGR in the endoscopy device market from 2022 to 2030.

The North American endoscopy device market is comprised of the US, Canada, and Mexico, with the US being the largest market in this region. The market growth is primarily driven by the increasing preference for minimally invasive surgeries and the rising prevalence of cancer. Additional factors contributing to market expansion include the introduction of advanced healthcare equipment, a higher number of hospitals, and the implementation of strategic government policies. Furthermore, the demand for automated systems due to the growing patient population and limited healthcare resources is anticipated to boost the adoption of endoscopy systems in the US. The emphasis on utilizing technologically advanced endoscopy devices equipped with high-definition cameras and light sources is also expected to significantly drive market growth during the forecast period.

Endoscopy Device Market Report Scope

Industry Developments and Future Opportunities:

Key initiatives undertaken by major players in the endoscopy device market include:

1. In February 2023, Boston Scientific Corp announced FDA approval for its LithoVue Elite Single-Use Digital Flexible Ureteroscope System, the first ureteroscope capable of monitoring intrarenal pressure in real-time during ureteroscopy procedures. This system includes the StoneSmart Connect Console, which enhances image quality, control features, and integration.
2. In September 2023, Ambu expanded its gastroenterology portfolio with the introduction of the Ambu aScope Gastro Large and Ambu aBox 2, two new larger-sized gastroscopy solutions set to launch in Europe. The Ambu aScope Gastro Large is notable for being the first gastroscope globally with a 4.2 mm operating channel, allowing for superior suction performance during procedures in the ICU and endoscopy unit, and is also the first endoscope made from bioplastic materials.
3. In September 2022, Medtronic plc announced FDA approval for the Nexpowder endoscopic hemostasis system, which is distributed globally by Medtronic and developed by NEXTBIOMEDICAL CO., LTD (Korea). This system utilizes a catheter with patented powder-coating technology to spray a noncontact, nonthermal, and nontraumatic hemostatic powder.
4. In September 2023, Stryker Corp launched the 1788 platform, a next-generation minimally invasive surgical camera system. This camera platform features upgraded technology for use in advanced surgeries across multiple specialties, providing vibrant images with balanced lighting to enhance visualization of blood flow and critical anatomy, and can visualize multiple optical imaging agents.

Competitive Landscape and Key Companies:

Prominent companies in the endoscopy device market include Boston Scientific Corp, Medtronic Plc, Stryker Corp, Johnson & Johnson, Karl Storz SE & Co KG, Olympus Corp, Ambu AS, Conmed Corp, B Braun SE, and PENTAX Medical. These companies are focused on developing new technologies, enhancing existing products, and expanding geographically to meet the growing global consumer demand.

This product will be delivered within 3-5 business days.